Graham Capital Management »

C4 Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $90k 41k 2.22
2024-03-31 $388k 47k 8.17
2023-06-30 $91k 33k 2.75

More positions owned by Graham Capital Management

Strategy Cl A New (MSTR)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Fidelity Wise Origin Bitcoin SHS Put Option (FBTC)
Eos Energy Enterprises Com Cl A Put Option (EOSE)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Vaneck Etf Trust Gold Miners Etf (GDX)
Tilray Brands Note 5.200% 6/1 (Principal)
Sunrun Note 4.000% 3/0 (Principal)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Rivian Automotive Note 3.625%10/1 (Principal)

View all positions for Graham Capital Management

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Soleus Capital Management
OrbiMed Advisors
Daniel D. Thurber
Morgan Stanley
Vanguard Group
Millennium Management
Silverarc Capital Management
BlackRock
Bain Capital Life Sciences Investors
Renaissance Technologies
Tang Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management

View all funds holding C4 Therapeutics